Amylyx Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: AMLX
Amylyx Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker AMLX. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2020.
Amylyx Pharmaceuticals at a glance
What does Amylyx Pharmaceuticals do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $30 million sold (2020).
Frequently asked questions about Amylyx Pharmaceuticals
Where is Amylyx Pharmaceuticals headquartered?
Amylyx Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Amylyx Pharmaceuticals do?
Amylyx Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Amylyx Pharmaceuticals a public company?
Yes. Amylyx Pharmaceuticals, Inc. trades on Nasdaq under the ticker AMLX.
When was Amylyx Pharmaceuticals founded?
The earliest incorporation on record for Amylyx Pharmaceuticals, Inc. is in 2014, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.